ラクオリア創薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/27 | 1,220 | 1,235 | 1,203 | 1,206 | +8 | +0.7% | 142,000 |
| 2022/12/26 | 1,222 | 1,222 | 1,197 | 1,198 | -16 | -1.3% | 112,100 |
| 2022/12/23 | 1,200 | 1,222 | 1,194 | 1,214 | +7 | +0.6% | 173,500 |
| 2022/12/22 | 1,250 | 1,250 | 1,206 | 1,207 | -43 | -3.4% | 247,000 |
| 2022/12/21 | 1,250 | 1,265 | 1,235 | 1,250 | +15 | +1.2% | 148,000 |
| 2022/12/20 | 1,300 | 1,300 | 1,220 | 1,235 | -61 | -4.7% | 401,500 |
| 2022/12/19 | 1,332 | 1,336 | 1,288 | 1,296 | -39 | -2.9% | 231,600 |
| 2022/12/16 | 1,359 | 1,364 | 1,333 | 1,335 | -32 | -2.3% | 189,300 |
| 2022/12/15 | 1,357 | 1,374 | 1,342 | 1,367 | +9 | +0.7% | 137,700 |
| 2022/12/14 | 1,399 | 1,414 | 1,358 | 1,358 | -39 | -2.8% | 261,900 |
| 2022/12/13 | 1,417 | 1,421 | 1,385 | 1,397 | +4 | +0.3% | 236,700 |
| 2022/12/12 | 1,375 | 1,414 | 1,371 | 1,393 | +6 | +0.4% | 210,100 |
| 2022/12/09 | 1,354 | 1,396 | 1,339 | 1,387 | +41 | +3% | 254,500 |
| 2022/12/08 | 1,359 | 1,359 | 1,334 | 1,346 | -9 | -0.7% | 116,800 |
| 2022/12/07 | 1,327 | 1,355 | 1,312 | 1,355 | +18 | +1.3% | 247,700 |
| 2022/12/06 | 1,339 | 1,350 | 1,333 | 1,337 | -2 | -0.1% | 143,200 |
| 2022/12/05 | 1,340 | 1,360 | 1,324 | 1,339 | -4 | -0.3% | 205,900 |
| 2022/12/02 | 1,338 | 1,355 | 1,319 | 1,343 | +3 | +0.2% | 139,600 |
| 2022/12/01 | 1,355 | 1,364 | 1,329 | 1,340 | -6 | -0.4% | 175,800 |
| 2022/11/30 | 1,365 | 1,367 | 1,334 | 1,346 | -30 | -2.2% | 237,500 |
| 2022/11/29 | 1,353 | 1,390 | 1,340 | 1,376 | +33 | +2.5% | 317,300 |
| 2022/11/28 | 1,326 | 1,362 | 1,319 | 1,343 | +7 | +0.5% | 206,300 |
| 2022/11/25 | 1,331 | 1,347 | 1,312 | 1,336 | -3 | -0.2% | 226,600 |
| 2022/11/24 | 1,331 | 1,346 | 1,325 | 1,339 | +1 | +0.1% | 186,700 |
| 2022/11/22 | 1,319 | 1,358 | 1,309 | 1,338 | +28 | +2.1% | 305,700 |
| 2022/11/21 | 1,340 | 1,342 | 1,290 | 1,310 | -75 | -5.4% | 761,500 |
| 2022/11/18 | 1,375 | 1,400 | 1,304 | 1,385 | +155 | +12.6% | 1,971,900 |
| 2022/11/17 | 1,266 | 1,274 | 1,221 | 1,230 | -51 | -4% | 282,300 |
| 2022/11/16 | 1,290 | 1,305 | 1,269 | 1,281 | -11 | -0.9% | 291,700 |
| 2022/11/15 | 1,236 | 1,295 | 1,228 | 1,292 | +56 | +4.5% | 494,000 |
| 2022/11/14 | 1,125 | 1,258 | 1,118 | 1,236 | +126 | +11.4% | 911,400 |
| 2022/11/11 | 1,126 | 1,129 | 1,102 | 1,110 | -8 | -0.7% | 139,700 |
| 2022/11/10 | 1,108 | 1,119 | 1,100 | 1,118 | -4 | -0.4% | 89,900 |
| 2022/11/09 | 1,111 | 1,125 | 1,107 | 1,122 | +11 | +1% | 62,000 |
| 2022/11/08 | 1,114 | 1,129 | 1,110 | 1,111 | +4 | +0.4% | 70,900 |
| 2022/11/07 | 1,119 | 1,119 | 1,098 | 1,107 | -15 | -1.3% | 100,000 |
| 2022/11/04 | 1,122 | 1,137 | 1,120 | 1,122 | -16 | -1.4% | 91,300 |
| 2022/11/02 | 1,141 | 1,142 | 1,129 | 1,138 | -10 | -0.9% | 70,200 |
| 2022/11/01 | 1,157 | 1,182 | 1,140 | 1,148 | ±0 | ±0% | 114,800 |
| 2022/10/31 | 1,166 | 1,171 | 1,148 | 1,148 | -11 | -0.9% | 93,400 |
| 2022/10/28 | 1,140 | 1,168 | 1,140 | 1,159 | +4 | +0.3% | 89,300 |
| 2022/10/27 | 1,114 | 1,166 | 1,114 | 1,155 | +43 | +3.9% | 229,800 |
| 2022/10/26 | 1,116 | 1,135 | 1,106 | 1,112 | ±0 | ±0% | 123,600 |
| 2022/10/25 | 1,110 | 1,122 | 1,102 | 1,112 | +2 | +0.2% | 100,300 |
| 2022/10/24 | 1,122 | 1,128 | 1,091 | 1,110 | ±0 | ±0% | 160,800 |
| 2022/10/21 | 1,140 | 1,140 | 1,098 | 1,110 | -49 | -4.2% | 296,600 |
| 2022/10/20 | 1,085 | 1,245 | 1,070 | 1,159 | +61 | +5.6% | 1,851,700 |
| 2022/10/19 | 1,106 | 1,116 | 1,090 | 1,098 | -13 | -1.2% | 91,800 |
| 2022/10/18 | 1,076 | 1,115 | 1,076 | 1,111 | +29 | +2.7% | 173,800 |
| 2022/10/17 | 1,064 | 1,082 | 1,063 | 1,082 | +4 | +0.4% | 67,600 |
651～
700
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| 大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
| Ｃｈｏｒｄｉａ | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム
